Nucleic
acid probes are used for diverse applications in vitro,
in situ, and in vivo. In any setting, their power is limited by imperfect
selectivity (binding of undesired targets) and incomplete affinity
(binding is reversible, and not all desired targets bound). These
difficulties are fundamental, stemming from reliance on base pairing
to provide both selectivity and affinity. Shielded covalent (SC) probes
eliminate the longstanding trade-off between selectivity and durable
target capture, achieving selectivity via programmable base pairing
and molecular conformation change, and durable target capture via
activatable covalent cross-linking. In pure and mixed samples, SC
probes covalently capture complementary DNA or RNA oligo targets and
reject two-nucleotide mismatched targets with near-quantitative yields
at room temperature, achieving discrimination ratios of 2–3
orders of magnitude. Semiquantitative studies with full-length mRNA
targets demonstrate selective covalent capture comparable to that
for RNA oligo targets. Single-nucleotide DNA or RNA mismatches, including
nearly isoenergetic RNA wobble pairs, can be efficiently rejected
with discrimination ratios of 1–2 orders of magnitude. Covalent
capture yields appear consistent with the thermodynamics of probe/target
hybridization, facilitating rational probe design. If desired, cross-links
can be reversed to release the target after capture. In contrast to
existing probe chemistries, SC probes achieve the high sequence selectivity
of a structured probe, yet durably retain their targets even under
denaturing conditions. This previously incompatible combination of
properties suggests diverse applications based on selective and stable
binding of nucleic acid targets under conditions where base-pairing
is disrupted (e.g., by stringent washes in vitro or in situ, or by
enzymes in vivo).